Comparative study of restenosis therapy after stent implantation for arteriosclerosis obliterans of lower extremities
Yue-lin ZHU,Tong YU,Zhao LIU,Min ZHOU,Chen LIU,Tong QIAO,Dian HUANG,Ming ZHANG,Feng RAN,Wei WANG,Chang-jian LIU
DOI: https://doi.org/10.3969/j.issn.1674-7429.2018.01.007
2018-01-01
Abstract:Objective To observe the efficacy of various treatment methods of restenosis after stent implantation for arteriosclerosis obliterans (ASO) of lower extremities,and to discuss the prevention and treatment of restenosis after stent implantation.Method A total of 77 patients (107 limbs) with restenosis after lower limb artery stent implantation in Drum Tower Hospital of Nanjing from June 2014 to May 2017 were divided into open surgery (20 cases),hybridization (12 cases),intravascular 56 cases of angioplasty,3 cases of gene therapy,amputation in 16 cases.The duration of postoperative restenosis occlusion was 0.5-48 months postoperatively with an average of 12.27 months.Results 69 patients were followed up,the follow-up rate was 88.23％.Follow-up time of 3 to 24 months,an average of 12.2 months.There were 39 cases of stent restenosis during follow-up,the incidence rate was 56.52％.There was no significant difference between the two groups at 3 months and 6 months after operation (P＞0.05).After 12 months,there was a difference between the groups in the treatment effect,the difference was statistically significant (P=0.049).At 24 months after operation,there was a significant difference between the two groups.The restenosis rate was the lowest in surgical bypass surgery group (15.00％) and the highest in restenosis group (78.57％) in balloon-only group.Conclusions In clinical treatment,individualized treatment plans should be tailored to the specific circumstances of each patient.In the treatment of primary disease,we must also be careful treatment of repeated endovascular treatment.Try to avoid excessive stent implantation.When necessary,should be accompanied by open surgery,postoperative formal drug treatment.